US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
US5049578A
(en)
|
1990-03-09 |
1991-09-17 |
E. R. Squibb & Sons, Inc. |
1-aroyl or 1-acyl-2-2pyrrolidinyl-3,5-dihydroxy alkanoic and alkenoic acids, salts, esters and lactones
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
CN1229110C
(zh)
|
1997-07-29 |
2005-11-30 |
阿尔康实验室公司 |
含半乳甘露聚糖聚合物和硼酸盐的眼用组合物
|
JP2002501892A
(ja)
|
1998-01-29 |
2002-01-22 |
セプラコア インコーポレーテッド |
光学的に純粋な(−)−ビュープロピオンの薬学的使用
|
US6372757B1
(en)
|
1998-05-08 |
2002-04-16 |
Smithkline Beecham P.L.C. |
Phenylurea and phenylthio urea derivatives
|
WO2000047576A1
(en)
|
1999-02-12 |
2000-08-17 |
Smithkline Beecham Plc |
Cinnamide derivatives as orexin-1 receptors antagonists
|
ES2226785T3
(es)
|
1999-02-12 |
2005-04-01 |
Smithkline Beecham Plc |
Derivados de fenilurea como antagonistas de los receptores de orexina.
|
ATE282614T1
(de)
|
1999-02-12 |
2004-12-15 |
Smithkline Beecham Plc |
Phenylharnstoff und phenylthioharnstoffderivate
|
US6638980B1
(en)
|
1999-05-24 |
2003-10-28 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
CA2408343A1
(en)
|
2000-05-11 |
2002-11-07 |
Banyu Pharmaceutical Co., Ltd. |
N-acyltetrahydroisoquinoline derivatives
|
ES2238458T3
(es)
|
2000-06-16 |
2005-09-01 |
Smithkline Beecham Plc |
Piperidinas para uso como antagonistas de los receptores de orexina.
|
ES2234929T3
(es)
|
2000-11-28 |
2005-07-01 |
Smithkline Beecham Plc |
Derivados de morfolina como antagonistas de los receptores de orexina.
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
AU2002341123A1
(en)
|
2001-05-05 |
2002-11-18 |
Smithkline Beecham P.L.C. |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
DE60224521T2
(de)
|
2001-05-05 |
2009-01-08 |
Smithkline Beecham P.L.C., Brentford |
Cyclische N-Aroylamine
|
GB0115862D0
(en)
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
GB0126292D0
(en)
|
2001-11-01 |
2002-01-02 |
Smithkline Beecham Plc |
Compounds
|
GB0127145D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Compounds
|
GB0130393D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
GB0130341D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
GB0130335D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
DE60311101T2
(de)
|
2002-07-09 |
2007-06-21 |
Actelion Pharmaceuticals Ltd. |
7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido und 2,3-dihydro-2h-pyrrolo (2,1-b)-chinazolinon-derivate
|
DE60309481T2
(de)
|
2002-09-18 |
2007-06-21 |
Glaxo Group Ltd., Greenford |
Cyclische n-aroylamine als orexinrezeptorantagonisten
|
WO2004033418A2
(en)
|
2002-10-11 |
2004-04-22 |
Actelion Pharmaceuticals Ltd. |
Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
|
GB0225944D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225884D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225938D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
AU2003299648A1
(en)
|
2002-12-12 |
2004-06-30 |
Janssen Pharmaceutica, N.V. |
Substituted 4-phenyl-(1,3)-dioxanes
|
JP4637089B2
(ja)
|
2003-03-26 |
2011-02-23 |
アクテリオン ファーマシューティカルズ リミテッド |
アセトアミド誘導体
|
US7538109B2
(en)
|
2003-04-28 |
2009-05-26 |
Actelion Pharmaceuticals Ltd |
Quinoxalin-3-one derivatives as orexin receptor antagonists
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
BRPI0413381A
(pt)
|
2003-08-07 |
2006-10-17 |
Allergan Inc |
composições para liberação de compostos terapêuticos nos olhos e processos para fabricação e uso das mesmas
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
HUP0304101A3
(en)
|
2003-12-22 |
2008-10-28 |
Sanofi Aventis |
Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
SI1751111T1
(sl)
|
2004-03-01 |
2015-04-30 |
Actelion Pharmaceuticals Ltd. |
Substituirani 1,2,3,4-tetrahidroizokinolinski derivati
|
WO2006067224A2
(en)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
|
WO2006110626A1
(en)
|
2005-04-12 |
2006-10-19 |
Merck & Co., Inc. |
Amidopropoxyphenyl orexin receptor antagonists
|
EP1885892A2
(en)
|
2005-05-03 |
2008-02-13 |
Ensemble Discovery Corporation |
Turnover probes and use thereof for nucleic acid detection
|
WO2006127550A1
(en)
|
2005-05-23 |
2006-11-30 |
Merck & Co., Inc. |
Proline bis-amide orexin receptor antagonists
|
AU2006278575A1
(en)
|
2005-08-04 |
2007-02-15 |
Merck & Co., Inc. |
Aminoethane sulfonamide orexin receptor antagonists
|
US20090176789A1
(en)
|
2005-08-26 |
2009-07-09 |
Breslin Michael J |
Diazaspirodecane orexin receptor antagonists
|
US20090088452A1
(en)
|
2005-11-22 |
2009-04-02 |
Coleman Paul J |
Indole Orexin Receptor Antagonists
|
CN101009515A
(zh)
|
2006-01-24 |
2007-08-01 |
华为技术有限公司 |
通信终端设备管理方法及通信终端
|
TW200800020A
(en)
|
2006-01-26 |
2008-01-01 |
Basf Ag |
Methods to use 3-pyridyl derivatives as pesticides
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
FR2896799B1
(fr)
|
2006-02-02 |
2008-03-28 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
US20090105318A1
(en)
|
2006-03-29 |
2009-04-23 |
Coleman Paul J |
Amidoethylthioether Orexin Receptor Antagonists
|
US8003654B2
(en)
|
2006-04-11 |
2011-08-23 |
Actelion Pharmaceuticals Ltd. |
N-glycinsulfonamide derivatives and uses as orexin receptor antagonists
|
WO2007122591A2
(en)
|
2006-04-26 |
2007-11-01 |
Actelion Pharmaceuticals Ltd |
Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
|
WO2007143813A1
(en)
|
2006-06-16 |
2007-12-21 |
Husky Injection Molding Systems Ltd. |
Preventative maintenance update system
|
JP2009543790A
(ja)
|
2006-07-14 |
2009-12-10 |
メルク エンド カムパニー インコーポレーテッド |
2−置換プロリンビス−アミドオレキシン受容体アンタゴニスト
|
JP5479893B2
(ja)
|
2006-07-14 |
2014-04-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
置換ジアゼパンオレキシン受容体アンタゴニスト
|
WO2008008517A2
(en)
|
2006-07-14 |
2008-01-17 |
Merck & Co., Inc. |
Bridged diazepan orexin receptor antagonists
|
US7994336B2
(en)
|
2006-08-15 |
2011-08-09 |
Actelion Pharmaceuticals Ltd. |
Azetidine compounds as orexin receptor antagonists
|
ES2339822T3
(es)
|
2006-08-28 |
2010-05-25 |
Actelion Pharmaceuticals Ltd. |
Derivados de 1,4,5,6,7,8-hexahidro-1,2,5-triaza-azuleno como antagonistas del receptor de orexina.
|
JP2010504957A
(ja)
|
2006-09-29 |
2010-02-18 |
アクテリオン ファーマシューティカルズ リミテッド |
3−アザ−ビシクロ[3.1.0]ヘキサン誘導体
|
US8133901B2
(en)
|
2006-12-01 |
2012-03-13 |
Actelion Pharmaceuticals Ltd. |
3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
EP2125823B1
(en)
|
2006-12-22 |
2012-02-15 |
Actelion Pharmaceuticals Ltd. |
5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
|
CL2007003827A1
(es)
|
2006-12-28 |
2008-09-26 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de n-(2-aza-biciclo(3.1.0)hex-3-ilmetil)amida; y su uso para prevenir o tratar la depresion, neurosis, esquizofrenia, ansiedad, adicciones, epilepsia, dolor, enfermedades cardiacas, entre otras.
|
WO2008087611A2
(en)
|
2007-01-19 |
2008-07-24 |
Actelion Pharmaceuticals Ltd |
Pyrrolidine- and piperidine- bis-amide derivatives
|
EP2131654A4
(en)
|
2007-03-02 |
2011-02-02 |
Merck Sharp & Dohme |
BIPYRIDINE CARBOXAMIDES, ANTAGONISTS OF THE OREXIN RECEPTOR
|
BRPI0808348A2
(pt)
|
2007-03-05 |
2014-07-15 |
Hoffmann La Roche |
Aminoamidas como antagonistas de orexina
|
ATE506343T1
(de)
|
2007-03-15 |
2011-05-15 |
Hoffmann La Roche |
Malonamide als orexin-antagonisten
|
CL2008000836A1
(es)
|
2007-03-26 |
2008-11-07 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras.
|
WO2008122513A1
(en)
|
2007-04-04 |
2008-10-16 |
F. Hoffmann-La Roche Ag |
Heterocycles as orexin antagonists
|
DE602008002934D1
(de)
|
2007-05-14 |
2010-11-18 |
Actelion Pharmaceuticals Ltd |
2-cyclopropylthiazolderivate
|
EP2150114A4
(en)
|
2007-05-18 |
2012-01-18 |
Merck Sharp & Dohme |
OXO-BRIDGED DIAZEPANOREXINE RECEPTOR ANTAGONISTS
|
WO2008150364A1
(en)
|
2007-05-23 |
2008-12-11 |
Merck & Co., Inc. |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
RU2470021C2
(ru)
|
2007-05-23 |
2012-12-20 |
Мерк Шарп Энд Домэ Корп. |
Пиридилпиперидиновые антагонисты рецептора орексинов
|
KR20100041805A
(ko)
|
2007-07-03 |
2010-04-22 |
액테리온 파마슈티칼 리미티드 |
3-아자-비시클로[3.3.0]옥탄 화합물
|
RU2478099C2
(ru)
|
2007-07-27 |
2013-03-27 |
Актелион Фармасьютиклз Лтд |
Производные 2-аза-бицикло[3.3.0]октана
|
TW200904799A
(en)
|
2007-07-27 |
2009-02-01 |
Actelion Pharmaceuticals Ltd |
Trans-3-aza-bicyclo[3.1.0]hexane derivatives
|
KR101171485B1
(ko)
|
2007-08-02 |
2012-08-07 |
에프. 호프만-라 로슈 아게 |
오렉신 수용체 길항제로서의 모노아마이드 유도체
|
US8003797B2
(en)
|
2007-08-09 |
2011-08-23 |
Merck Sharp & Dohme Corp. |
Pyridine carboxamide orexin receptor antagonists
|
SG163526A1
(en)
|
2007-08-10 |
2010-08-30 |
Cortex Pharma Inc |
Bicyclic amides for enhancing glutamatergic synaptic responses
|
US20110263662A1
(en)
|
2007-08-15 |
2011-10-27 |
Hamed Aissaoui |
1,2-diamido-ethylene derivatives as orexin antagonists
|
JP2010540429A
(ja)
|
2007-09-24 |
2010-12-24 |
アクテリオン ファーマシューティカルズ リミテッド |
オレキシン受容体拮抗薬としてのピロリジン類及びピペリジン類
|
AU2008319419A1
(en)
|
2007-10-29 |
2009-05-07 |
Merck Sharp & Dohme Corp. |
Substituted diazepan orexin receptor antagonists
|
WO2009079637A1
(en)
|
2007-12-18 |
2009-06-25 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
KR101204213B1
(ko)
|
2007-12-21 |
2012-11-26 |
에프. 호프만-라 로슈 아게 |
오렉신 수용체 길항제로서의 헤테로아릴 유도체
|
WO2009092642A1
(en)
|
2008-01-21 |
2009-07-30 |
F. Hoffmann-La Roche Ag |
Sulfonamides as orexin antagonists
|
WO2009100994A1
(en)
|
2008-02-12 |
2009-08-20 |
F. Hoffmann-La Roche Ag |
Piperidine sulfonamide derivatives
|
CN101965343A
(zh)
|
2008-02-21 |
2011-02-02 |
埃科特莱茵药品有限公司 |
2-氮杂-双环[2.2.1]庚烷衍生物
|
GB0806536D0
(en)
|
2008-04-10 |
2008-05-14 |
Glaxo Group Ltd |
Novel compounds
|
EP2288603A1
(en)
|
2008-06-11 |
2011-03-02 |
Actelion Pharmaceuticals Ltd. |
Tetrazole compounds as orexin receptor antagonists
|
MX2010013192A
(es)
|
2008-06-16 |
2010-12-17 |
Hoffmann La Roche |
Monoamidas heteroaromaticas como antagonistas de receptor orexinina.
|
CA2726834A1
(en)
|
2008-06-25 |
2009-12-30 |
Actelion Pharmaceuticals Ltd |
5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
|
CA2729985A1
(en)
|
2008-07-07 |
2010-01-14 |
Actelion Pharmaceuticals Ltd |
Thiazolidine compounds as orexin receptor antagonists
|
KR101359852B1
(ko)
|
2008-07-29 |
2014-02-06 |
에프. 호프만-라 로슈 아게 |
오렉신 길항제로서 피롤리딘-3-일메틸-아민
|
AR072899A1
(es)
|
2008-08-07 |
2010-09-29 |
Merck Sharp & Dohme |
Derivados de terpiridina-carboxamida antagonistas de receptores de orexina, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del insomnio y la obesidad.
|
EP2161266A1
(en)
|
2008-08-22 |
2010-03-10 |
EVOTEC Neurosciences GmbH |
Benzofuran derivatives as orexin receptor antagonists
|
WO2010038200A1
(en)
|
2008-10-01 |
2010-04-08 |
Actelion Pharmaceuticals Ltd |
Oxazolidine compounds as orexin receptor antagonists
|
RU2011119217A
(ru)
|
2008-10-14 |
2012-11-27 |
Актелион Фармасьютикалз Лтд |
Производные фенетиламида и их гетероциклические аналоги
|
CA2739916A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted piperidine orexin receptor antagonists
|
WO2010048016A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,3-disubstituted piperidine orexin receptor antagonists
|
AU2009307916A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted morpholine orexin receptor antagonists
|
CA2739927A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Disubstituted azepan orexin receptor antagonists
|
JP2012506374A
(ja)
|
2008-10-21 |
2012-03-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
2,5−二置換ピペリジンオレキシン受容体アンタゴニスト
|
AU2009307918A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,4-disubstituted pyrrolidine orexin receptor antagonists
|
CA2741644C
(en)
|
2008-10-30 |
2013-05-07 |
Merck Sharp & Dohme Corp. |
Isonicotinamide orexin receptor antagonists
|
CA2741648A1
(en)
|
2008-10-30 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted phenyl carboxamide orexin receptor antagonists
|
JP2012507540A
(ja)
|
2008-10-30 |
2012-03-29 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ピリダジンカルボキサミド・オレキシン受容体アンタゴニスト
|
WO2010060470A1
(en)
|
2008-11-26 |
2010-06-03 |
Glaxo Group Limited |
Piperidine derivatives useful as orexin receptor antagonists
|
WO2010060471A1
(en)
|
2008-11-26 |
2010-06-03 |
Glaxo Group Limited |
Piperidine derivatives useful as orexin receptor antagonists
|
JP2012509912A
(ja)
|
2008-11-26 |
2012-04-26 |
グラクソ グループ リミテッド |
新規の化合物
|
EA201170742A1
(ru)
|
2008-12-02 |
2012-01-30 |
Глэксо Груп Лимитед |
Производные n-{[(1r,4s,6r)-3-(2-пиридинилкарбонил)-3-азабицикло[4.1.0]гепт-4-ил]метил}-2-гетероариламинов и их применения
|
EA201170741A1
(ru)
|
2008-12-02 |
2011-12-30 |
Глэксо Груп Лимитед |
Производные n-{[(1r,4s,6r)-3-(2-пиридинилкарбонил)-3-азабицикло[4.1.0]гепт-4-ил]метил}-2-гетероариламина и их применения
|
JP2010155827A
(ja)
|
2008-12-04 |
2010-07-15 |
Takeda Chem Ind Ltd |
スピロ環化合物
|
GB0823467D0
(en)
|
2008-12-23 |
2009-01-28 |
Glaxo Group Ltd |
Novel Compounds
|
WO2010086366A1
(en)
|
2009-01-30 |
2010-08-05 |
Novartis Ag |
4-aryl-butane-1,3-diamides
|
AU2010240871A1
(en)
|
2009-04-24 |
2011-10-27 |
Glaxo Group Limited |
3 -azabicyclo [4.1.0] heptanes used as orexin antagonists
|
EP2451281A4
(en)
|
2009-07-09 |
2013-03-13 |
Merck Sharp & Dohme |
ANTAGONISTS OF OREXIN RECEPTORS BASED ON TETRAHYDRONAPHTHYRIDINE
|
EP2275421A1
(en)
|
2009-07-15 |
2011-01-19 |
Rottapharm S.p.A. |
Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
|
WO2011016234A1
(en)
|
2009-08-04 |
2011-02-10 |
Raqualia Pharma Inc. |
Picolinamide derivatives as ttx-s blockers
|
JP2013502447A
(ja)
|
2009-08-24 |
2013-01-24 |
グラクソ グループ リミテッド |
睡眠障害の治療のためのオレキシン受容体アンタゴニストとしての5−メチル−ピペリジン誘導体
|
WO2011023585A1
(en)
|
2009-08-24 |
2011-03-03 |
Glaxo Group Limited |
Piperidine derivatives used as orexin antagonists
|
JP5759470B2
(ja)
|
2009-10-23 |
2015-08-05 |
ヤンセン ファーマシューティカ エヌ.ベー. |
オレキシン受容体調節因子としての二置換オクタヒドロピロロ[3,4−c]ピロール
|
US8680275B2
(en)
|
2009-10-23 |
2014-03-25 |
Janssen Pharmaceutica Nv |
Fused heterocyclic compounds as orexin receptor modulators
|
JP5848251B2
(ja)
|
2009-10-23 |
2016-01-27 |
ヤンセン ファーマシューティカ エヌ.ベー. |
オレキシン受容体調節因子としての縮合複素環式化合物
|
WO2011053522A1
(en)
|
2009-10-29 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Tertiary amide orexin receptor antagonists
|
EP2504316A1
(en)
|
2009-11-23 |
2012-10-03 |
MSD Oss B.V. |
Heterocylic compounds as antagonists of the orexin receptors
|
WO2011073316A1
(en)
|
2009-12-18 |
2011-06-23 |
Novartis Ag |
4-aryl-butane-1,3-diamides
|
EP2516439B1
(en)
|
2009-12-21 |
2014-01-22 |
Novartis AG |
Diaza-spiro[5.5]undecanes as orexin receptor antagonists
|
US8742106B2
(en)
|
2009-12-21 |
2014-06-03 |
Novartis Ag |
Disubstituted heteroaryl-fused pyridines
|
WO2011138265A2
(en)
|
2010-05-03 |
2011-11-10 |
Evotec Ag |
Indole and indazole derivatives as orexin receptor antagonists
|
WO2011138266A1
(en)
|
2010-05-03 |
2011-11-10 |
Evotec Ag |
Indolizine and imidazopyridine derivatives as orexin receptor antagonists
|
RU2013132930A
(ru)
|
2010-12-17 |
2015-01-27 |
Тайсо Фармасьютикал Ко., Лтд. |
Производное пиразола
|
US20120165331A1
(en)
|
2010-12-22 |
2012-06-28 |
Sangamesh Badiger |
Di/tri-aza-spiro-C9-C11alkanes
|
US20120165339A1
(en)
|
2010-12-22 |
2012-06-28 |
Eisai R&D Management Co., Ltd. |
Cyclopropane derivatives
|
WO2012085852A1
(en)
|
2010-12-22 |
2012-06-28 |
Actelion Pharmaceuticals Ltd |
3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
|
WO2012089607A1
(en)
|
2010-12-28 |
2012-07-05 |
Glaxo Group Limited |
Novel compounds with a 3a-azabicyclo [4.1.0] heptane core acting on orexin receptors
|
WO2012089606A1
(en)
|
2010-12-28 |
2012-07-05 |
Glaxo Group Limited |
Azabicyclo [4.1.0] hept - 4 - yl derivatives as human orexin receptor antagonists
|
JP5987005B2
(ja)
|
2011-02-18 |
2016-09-06 |
アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd |
オレキシン拮抗薬として有用な新規なピラゾール及びイミダゾール誘導体
|
WO2012114252A1
(en)
|
2011-02-21 |
2012-08-30 |
Actelion Pharmaceuticals Ltd |
Novel indole and pyrrolopyridine amides
|
US9586962B2
(en)
|
2011-04-20 |
2017-03-07 |
Janssen Pharmaceutica Nv |
Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
|
JPWO2012153729A1
(ja)
|
2011-05-10 |
2014-07-31 |
大正製薬株式会社 |
ヘテロ芳香環誘導体
|
WO2013005755A1
(ja)
|
2011-07-05 |
2013-01-10 |
大正製薬株式会社 |
メチルピペリジン誘導体
|
WO2013050938A1
(en)
|
2011-10-04 |
2013-04-11 |
Actelion Pharmaceuticals Ltd |
3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
WO2013059163A1
(en)
|
2011-10-21 |
2013-04-25 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted thiomorpholine orexin receptor antagonists
|
US8940898B2
(en)
|
2011-10-25 |
2015-01-27 |
Merck Sharp & Dohme Corp. |
Piperidinyl alkyne orexin receptor antagonists
|
WO2013062858A1
(en)
|
2011-10-25 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Isoxazolopyridine orexin receptor antagonists
|
CN103917538B
(zh)
|
2011-11-08 |
2016-08-24 |
埃科特莱茵药品有限公司 |
2-(1,2,3-***-2-基)苯甲酰胺及3-(1,2,3-***-2-基)吡啶酰胺衍生物
|
ITMI20112329A1
(it)
|
2011-12-21 |
2013-06-22 |
Rottapharm Spa |
Nuovi derivati spiro amminici
|
WO2013119639A1
(en)
|
2012-02-07 |
2013-08-15 |
Eolas Therapeutics, Inc. |
Substituted prolines / piperidines as orexin receptor antagonists
|
US9440982B2
(en)
|
2012-02-07 |
2016-09-13 |
Eolas Therapeutics, Inc. |
Substituted prolines/piperidines as orexin receptor antagonists
|
RU2617696C2
(ru)
|
2012-02-17 |
2017-04-26 |
ЭЙСАЙ Ар ЭНД Ди МЕНЕДЖМЕНТ КО., ЛТД |
Способы и соединения, которые можно использовать для синтеза антагонистов рецепторов орексина-2
|
ITMI20120322A1
(it)
*
|
2012-03-01 |
2013-09-02 |
Rottapharm Spa |
Composti di 4,4-difluoro piperidina
|
ITMI20120424A1
(it)
|
2012-03-19 |
2013-09-20 |
Rottapharm Spa |
Composti chimici
|
WO2015123355A1
(en)
|
2014-02-12 |
2015-08-20 |
Eolas Therapeutics, Inc. |
Substituted prolines / piperidines as orexin receptor antagonists
|